miR-425-5p suppresses tumorigenesis and DDP resistance in human-prostate cancer by targeting GSK3β and inactivating the Wnt/β-catenin signaling pathway
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR-425-5p suppresses tumorigenesis and DDP resistance in human-prostate cancer by targeting GSK3β and inactivating the Wnt/β-catenin signaling pathway
Authors
Keywords
β-Catenin, DDP resistance, GSK3β, miR-425-5p, prostate cancer (PCa)
Journal
JOURNAL OF BIOSCIENCES
Volume 44, Issue 4, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-08-09
DOI
10.1007/s12038-019-9920-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combining Prostate Health Index density, magnetic resonance imaging and prior negative biopsy status to improve the detection of clinically significant prostate cancer
- (2018) Sasha C. Druskin et al. BJU INTERNATIONAL
- Role of MicroRNAs in Treatment Response in Prostate Cancer
- (2018) Anshuli Razdan et al. CURRENT CANCER DRUG TARGETS
- LINE-1 as a therapeutic target for castration-resistant prostate cancer
- (2018) Philippe Pourquier Frontiers in Bioscience-Landmark
- Role of Wnt signalling in advanced prostate cancer
- (2018) Imran Ahmad et al. JOURNAL OF PATHOLOGY
- A designer bow-tie combination therapeutic platform: An approach to resistant cancer treatment by simultaneous delivery of cytotoxic and anti-inflammatory agents and radiation
- (2018) Rakesh K. Pathak et al. BIOMATERIALS
- miRNA expression profiles of premalignant and malignant arsenic-induced skin lesions
- (2018) Laila Al-Eryani et al. PLoS One
- Adipose stromal cell targeting suppresses prostate cancer epithelial-mesenchymal transition and chemoresistance
- (2018) Fei Su et al. ONCOGENE
- Androgen deprivation therapy for the treatment of prostate cancer: a focus on pharmacokinetics
- (2017) Charles F. Polotti et al. Expert Opinion on Drug Metabolism & Toxicology
- The Diagnosis and Treatment of Prostate Cancer
- (2017) Mark S. Litwin et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- WNT signalling in prostate cancer
- (2017) Virginia Murillo-Garzón et al. Nature Reviews Urology
- Newly Diagnosed Metastatic Prostate Cancer: Has the Paradigm Changed?
- (2017) Shivashankar Damodaran et al. UROLOGIC CLINICS OF NORTH AMERICA
- MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer
- (2017) Liwei Sun et al. ANNALS OF CLINICAL BIOCHEMISTRY
- A Tale of Two Signals: AR and WNT in Development and Tumorigenesis of Prostate and Mammary Gland
- (2017) Hubert Pakula et al. Cancers
- Potential therapeutic value of miR-425-5p in metastatic colorectal cancer
- (2016) Ion Cristóbal et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- The Oncogenic MicroRNA-21 Inhibits the Tumor Suppressive Activity of FBXO11 to Promote Tumorigenesis
- (2015) Chuan He Yang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNA-425-5p regulates chemoresistance in colorectal cancer cells via regulation of Programmed Cell Death 10
- (2015) Ye Zhang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- microRNA-425-5p is upregulated in human gastric cancer and contributes to invasion and metastasis in vitro and in vivo
- (2015) ZHUOQI ZHANG et al. Experimental and Therapeutic Medicine
- Prostate cancer: the need for biomarkers and new therapeutic targets
- (2014) Juliana Felgueiras et al. Journal of Zhejiang University-SCIENCE B
- Mitotic Wnt Signaling Promotes Protein Stabilization and Regulates Cell Size
- (2014) Sergio P. Acebron et al. MOLECULAR CELL
- Activation of Wnt/β-catenin signaling in a subpopulation of murine prostate luminal epithelial cells induces high grade prostate intraepithelial neoplasia
- (2014) Kenneth C. Valkenburg et al. PROSTATE
- Differential expression of the multidrug resistance 1 (MDR1) protein in prostate cancer cells is independent from anticancer drug treatment and Y box binding protein 1 (YB-1) activity
- (2014) Madeleine Saupe et al. WORLD JOURNAL OF UROLOGY
- Therapeutic Potential of an Anti-diabetic Drug, Metformin: Alteration of miRNA expression in Prostate Cancer Cells
- (2013) Cigir Biray Avci et al. Asian Pacific Journal of Cancer Prevention
- miR-205 impairs the autophagic flux and enhances cisplatin cytotoxicity in castration-resistant prostate cancer cells
- (2013) Marzia Pennati et al. BIOCHEMICAL PHARMACOLOGY
- Epigenetic regulation of MDR1 gene through post-translational histone modifications in prostate cancer
- (2013) Rui Henrique et al. BMC GENOMICS
- Relationship between multidrug resistance 1 polymorphisms and the risk of prostate cancer in Chinese populations
- (2013) F.R. Shen et al. GENETICS AND MOLECULAR RESEARCH
- MicroRNA-205, a novel regulator of the anti-apoptotic protein Bcl2, is downregulated in prostate cancer
- (2013) BERLINDA VERDOODT et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Inhibitory effects of antagonists of growth hormone-releasing hormone on growth and invasiveness of PC3 human prostate cancer
- (2012) Laura Muñoz-Moreno et al. INTERNATIONAL JOURNAL OF CANCER
- miR-21: an oncomir on strike in prostate cancer
- (2010) Marco Folini et al. Molecular Cancer
- Expression of multidrug resistance proteins in prostate cancer is related with cell sensitivity to chemotherapeutic drugs
- (2009) Catherine Sánchez et al. PROSTATE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started